Immunoclin Corporation (IMCL) – Analyst Ratings
-
Janney Montgomery Scott Downgrades ImClone (IMCL) to Neutral
-
Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to IMCL Stock Lookup